Recent Device Approvals: Animas Vibe System

The FDA has recently approved the Animas Vibe System to be marketed.  The Animas Vibe System is a continuous glucose monitor (CGM) and insulin pump combination for people with diabetes. The CGM is an externally-worn device with an internal sensor that continuously measures glucose values in the fluid around the cells (interstitial glucose) for up to seven days (the life of the sensor). The insulin pump delivers insulin as a single dose (bolus) when needed or continuously throughout the day (basal insulin). The insulin pump displays glucose values from the CGM along with glucose trending information, alerts and alarms, and insulin pump data and information.  For more information, please see:

This email was sent to using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery